| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/29/2008 | US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX |
| 04/29/2008 | US7364866 Insecticides; generating immunology response |
| 04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives |
| 04/24/2008 | WO2008048045A1 Silk protein-mimicking peptides and compositions for preventing or treating cranial neuropathies comprising the same |
| 04/24/2008 | WO2008047792A1 Crystal of glutathione and process for production thereof |
| 04/24/2008 | WO2008046909A1 The histone deacetylase inhibitor helminthosporium carbonum toxin for suppressing malignant qualities of neuroblastoma cells |
| 04/24/2008 | WO2007121125A3 Hcv inhibitors |
| 04/24/2008 | US20080097078 Antibacterial activity against vancomycin-resistant bacteria |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080095715 Cyclic nonapeptides coupled to a cyanine dye as an imaging contrast agent; monitoring angiogenesis inhibition |
| 04/23/2008 | EP1913016A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 04/23/2008 | EP1913015A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1913014A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912999A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912997A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912996A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912995A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1411116B1 Peptide synthase gene, peptide synthase and process for producing dipeptide |
| 04/23/2008 | EP1272516B1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 04/23/2008 | CN101166756A Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 04/23/2008 | CN101166755A Single chain antibody with cleavable linker |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN100383160C Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 04/23/2008 | CN100383159C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 04/23/2008 | CN100383158C Method and compositions for peptide synthesis |
| 04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/22/2008 | US7361757 an N-protected morpholinone is reactedeither with allyl bromide or allyl triflate; hydrogenation; subjected to the action of LiOH, then esterification; chemical intermediates |
| 04/22/2008 | US7361730 Surface localized colligin/Hsp47 in carcinoma cells |
| 04/22/2008 | US7361458 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
| 04/22/2008 | CA2261902C Radiolabeled annexin conjugates whith hexose and a chelator |
| 04/17/2008 | WO2008045905A1 Pyrrolydine derivatives as iap inhibitors |
| 04/17/2008 | WO2008044798A1 Agent for introducing protein into cell |
| 04/17/2008 | US20080092254 Transgenic Plants with Reduced Level of Saturated Fatty Acid and Methods for Making Them |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | US20080090771 Modification of pharmacokinetic and pharmacological properties of hydrocodone through covalent modification by conjugating hydrocodone with a carrier selected from an amino acid, a dipeptide, a tripeptide, a tetrapeptide and a pentapeptide; analgesic; bioavailability |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080089842 solid phase peptide synthesis for a peptidyl contrast agent; synthesizing an amino-chelator loaded resin coupling the loaded resin to C-terminus and/or backbone of a peptide, cleaving the amino-chelator-peptide from a resin, and chelating a lanthanide metal; DOTA or DTPA chelate coupled to peptide |
| 04/17/2008 | CA2666112A1 Pyrrolydine derivatives as iap inhibitors |
| 04/16/2008 | EP1911839A1 Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method |
| 04/16/2008 | EP1911762A1 Amino alcohols and their use as renin inhibitors |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910404A1 Hcv ns3 protease inhibitors |
| 04/16/2008 | EP1910341A2 Inhibitors of serine proteases |
| 04/16/2008 | EP1833788B1 Process for preparing perindopril erbumine |
| 04/16/2008 | EP1309613B1 Pharmaceutical composition comprising an analgesic peptide |
| 04/16/2008 | CN101161674A Cyclopeptide, preparation method and uses thereof |
| 04/16/2008 | CN101161673A Method for preparing arginine-glycine- aspartic acid-N end dissociative amino acid or derivative cell adhesion tetrapeptide |
| 04/16/2008 | CN101161672A Method for preparing arginine-glycine-aspartic acid cell adhesion tripeptide |
| 04/16/2008 | CN100381459C Adriamycin derivative and its preparing method and use |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381418C Gelling agents |
| 04/15/2008 | US7358372 more especially its tert-butylamine salt; synthesis intermediates; carried out in the presence of an activation reagent selected from N-methyl-N-phenyl-aminotriphenylphosphonium iodide and hexamethylphosphorus triamide together with ammonium perchlorate by Mitsunobu reaction |
| 04/15/2008 | US7358335 ARF-BP1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 04/15/2008 | US7358330 oligopeptides derived from human chorionic gonadotropin (hCG); compositions exhibiting immunoregulatory activity as determined by measuring the compound's ability to modulate production of NO by a cell |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358264 Statine derivatives for the treatment of Alzheimer's disease |
| 04/15/2008 | US7357835 Production of crystalline materials by using high intensity ultrasound |
| 04/10/2008 | WO2008042634A2 Isotopically labeled trapping agent and method for identifying reactive metabolites |
| 04/10/2008 | WO2008040986A1 Short peptidic neuropilin-1 antagonists and their use |
| 04/10/2008 | WO2008040979A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008023378A9 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 04/10/2008 | WO2007142986A3 Aminothiazole derivatives and their uses as antibacterial agents |
| 04/10/2008 | WO2007107587A3 Cholesterol lowering protein hydrolysates |
| 04/10/2008 | US20080085889 Amidomethyl-Substituted 1-(Carboxyalkyl) Cyclopentyl-Carbonylamino-Benzazepine-N-Acetic Acid Compounds, Process and Intermediate Products for Their Preparation and Pharmaceutical Compositions Containing Them |
| 04/10/2008 | US20080085299 Peptides derived from colostrinin |
| 04/10/2008 | CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | CA2664904A1 Isotopically labeled trapping agent and method for identifying reactive metabolites |
| 04/10/2008 | CA2664842A1 Arginine derivatives with np-i antagonistic activity |
| 04/09/2008 | EP1907860A2 Mass labels |
| 04/09/2008 | EP1907857A2 Biomarkers for breast cancer |
| 04/09/2008 | EP1907413A2 Antibacterial amide macrocycles vii |
| 04/09/2008 | EP1907412A2 Peptides inhibiting angiotensin-converting enzyme |
| 04/09/2008 | EP1907403A2 Antiviral compounds |
| 04/09/2008 | EP1907015A2 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 04/09/2008 | EP1906945A2 Hcv inhibitors |
| 04/09/2008 | EP1824501A4 Protein hydrolysate with antidiabetic effect |
| 04/09/2008 | CN101160317A Process for preparing macrocyclic compounds |
| 04/09/2008 | CN101157924A Neutrophil leukocyte gene alpha |
| 04/09/2008 | CN101157720A Template fixed peptide analogue as serine protease inhibitor |
| 04/09/2008 | CN100379760C Peptides and compounds that bind to receptor |
| 04/09/2008 | CN100379722C New compounds |
| 04/08/2008 | US7354997 Polypeptide encoded by a nucleic acid underexpressed in stomach tumor |
| 04/08/2008 | US7354993 Insecticidal polypeptides and methods of use thereof |
| 04/08/2008 | US7354992 Expression vectors, eukaryotic and prokaryotic cell lines; cancer vaccines |
| 04/08/2008 | US7354943 Statine derivatives for the treatment of Alzheimer's disease |
| 04/08/2008 | US7354923 Piperazine melanocortin-specific compounds |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | US7354723 in vitro diagnostic test kit for osteoarthritis or rheumatoid arthritis by detecting tissue specific biochemical markers such as derives from perlecan, bigylcan, decorin, fibrillin-1 or protocadherin, or a sequence from aggrecan, cartilage intermediate layer protein (CILP); immunoassay |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/02/2008 | EP1905779A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 04/02/2008 | EP1905438A2 Hypoglycemic agent |
| 04/02/2008 | EP1904516A2 Hepatitis c virus inhibitors |
| 04/02/2008 | CN101153053A Bone-peptide, producing method, pharmaceutical composition and uses thereof |
| 04/02/2008 | CN101153052A Uridine peptide antibiotic, pharmaceutically acceptable salt, producing method and uses thereof |
| 04/02/2008 | CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN100378121C Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |